Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
Por um escritor misterioso
Descrição
American Journal of Hematology, Blood Research Journal
Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy
A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia
Cancers, Free Full-Text
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023
Promising Results in Phase 1 Study of Novel Menin Inhibitor for Aggressive Leukemia
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International
JPM, Free Full-Text
